Connecting you to content on EBSCOhost

Works by E. W. Gascoigne

Results: 3

1

Solvent/detergent treatment does not alter the tolerance or uptake of human normal immunoglobulin for intramuscular injection.

Published in:

Vox Sanguinis, 2001, v. 80, n. 3, p. 151, doi. 10.1046/j.1423-0410.2001.00026.x

By:

Mould, G. P.;
Sutton, J. A.;
Matejtschuk, P.;
Gascoigne, E. W.;
Dash, C. H.

Publication type:

Article

2

A retrospective survey on the safety of Replenine®, a high-purity factor IX concentrate (No conflict of interest was declared, other than the affiliation of the authors.).

Published in:

Pharmacoepidemiology & Drug Safety, 2004, v. 13, n. 3, p. 187, doi. 10.1002/pds.911

By:

E. W. Gascoigne;
C. H. Dash;
C. Harman;
D. Wilmot

Publication type:

Article

3

A retrospective survey on the safety of Replenate®, a high-purity factor VIII concentrate.

Published in:

Pharmacoepidemiology & Drug Safety, 2004, v. 13, n. 4, p. 243, doi. 10.1002/pds.956

By:

Gascoigne, E. W.;
Dash, C. H.;
Harman, C.;
Wilmot, D.

Publication type:

Article